EBS Financial Facts
Selling, general and administrative: 40.69MTotal other income (expense): -1.93M
See Full Income Statement
Commitments and contingencies: 0
Deferred tax assets, net: 0
See Full Balance Sheet
Emergent BioSolutions, Inc. (EBS) Earnings
|
Expand Research on EBS
| Next EPS Date | 8/6/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +51.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -10.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/13/26  |
Q126 | N/A | $0.86 | N/A | N/A | $275M | N/A | N/A | N/A | ||
| 2/26/26 | Q425 | -$0.43 | $0.38 | -$0.81 | $148.7M | $237M | N/A |  | | Details | |
| 10/29/25 |
Q325 | N/A | $0.05 | N/A | $231.1M | $203.67M | N/A | N/A | N/A | ||
| 8/6/25 |
Q225 | $0.16 | -$0.10 | +$0.26 | $140.9M | $174M | N/A | | | Details | |
| 5/7/25 |
Q125 | $0.71 | $0.49 | +$0.22 | $222.2M | $279M | N/A | | | Details | |
| 4/24/25 |
Q125 | N/A | $0.49 | N/A | N/A | $279M | N/A | N/A | N/A | ||
| 3/3/25 | Q424 | $0.05 | -$0.41 | +$0.46 | $194.7M | $243.33M | N/A | | | Details | |
| 2/20/25 |
Q424 | N/A | -$0.41 | N/A | N/A | $243.33M | = | N/A | N/A |
